{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:24:37Z","timestamp":1793381077462,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"DOI":"10.1186\/s13027-026-00777-0","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:33:49Z","timestamp":1783442029000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dynamic, transition and variation of cervicovaginal microbiome and HPV infection and cervical dysplasia and cancer: a systematic review"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3401-2547","authenticated-orcid":false,"given":"Gbenankpon Mathias","family":"Houvessou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8646-8586","authenticated-orcid":false,"given":"Nerys Wendy","family":"Antonieta Alfane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9784-6402","authenticated-orcid":false,"given":"Manuel","family":"Mahoche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"777_CR1","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/ijc.11222","volume":"106","author":"V Dalstein","year":"2003","unstructured":"Dalstein V, Riethmuller D, Pr\u00e9tet J, Le Bail Carval K, Sauti\u00e8re J, Carbillet J, Kantelip B, Schaal J, Mougin C. Persistence and load of high-risk HPV are predictors for development of high\u2010grade cervical lesions: A longitudinal French cohort study. Int J Cancer. 2003;106:396\u2013403. https:\/\/doi.org\/10.1002\/ijc.11222.","journal-title":"Int J Cancer"},{"issue":"199909189:112","key":"777_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(199909189:112):12\u20139. https:\/\/doi.org\/10.1002\/(SICI)1096-9896. ::AID-PATH431>3.0.CO;2-F.","journal-title":"J Pathol"},{"key":"777_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S1470-2045(01)00617-9","volume":"3","author":"A Ferenczy","year":"2002","unstructured":"Ferenczy A, Franco E. Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncol. 2002;3:11\u20136. https:\/\/doi.org\/10.1016\/S1470-2045(01)00617-9.","journal-title":"Lancet Oncol"},{"key":"777_CR4","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.15419\/bmrat.v4i12.386","volume":"4","author":"Z Momenimovahed","year":"2017","unstructured":"Momenimovahed Z, Salehiniya H. Incidence, mortality and risk factors of cervical cancer in the world. Biomed Res Ther. 2017;4:1795\u2013811. https:\/\/doi.org\/10.15419\/bmrat.v4i12.386.","journal-title":"Biomed Res Ther"},{"key":"777_CR5","doi-asserted-by":"publisher","first-page":"6806857","DOI":"10.1155\/2020\/6806857","volume":"2020","author":"P Moreno-Acosta","year":"2020","unstructured":"Moreno-Acosta P, Romero-Rojas A, Vial N, Huertas A, Acosta J, Mayorga D, Carrillo S, Molano M, Gamboa O, Cotes M, Casadiego C, Vallard A, Magne N. Persistent High-Risk HPV Infection and Molecular Changes Related to the Development of Cervical Cancer. Case Rep Obstet Gynecol. 2020;2020:6806857. https:\/\/doi.org\/10.1155\/2020\/6806857.","journal-title":"Case Rep Obstet Gynecol"},{"key":"777_CR6","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ygyno.2021.08.021","volume":"163","author":"S Wu","year":"2021","unstructured":"Wu S, Ding X, Kong Y, Acharya S, Wu H, Huang Cothers. The feature of cervical microbiota associated with the progression of cervical cancer among reproductive females. Gynecol Oncol. 2021;163:348\u201357. https:\/\/doi.org\/10.1016\/j.ygyno.2021.08.021.","journal-title":"Gynecol Oncol"},{"key":"777_CR7","doi-asserted-by":"publisher","first-page":"720","DOI":"10.21147\/j.issn.1000-9604.2020.06.05","volume":"32","author":"S Zhang","year":"2020","unstructured":"Zhang S, Xu H, Zhang L, Qiao Y. Cervical cancer: epidemiology, risk factors and screening. Chin J Cancer Res. 2020;32:720\u20138. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2020.06.05.","journal-title":"Chin J Cancer Res"},{"key":"777_CR8","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1146\/annurev-micro-092611-150157","volume":"66","author":"B Ma","year":"2012","unstructured":"Ma B, Forney LJ, Ravel J. Vaginal microbiome: rethinking health and disease. Annu Rev Microbiol. 2012;66:371\u201389. https:\/\/doi.org\/10.1146\/annurev-micro-092611-150157.","journal-title":"Annu Rev Microbiol"},{"key":"777_CR9","doi-asserted-by":"publisher","unstructured":"McClymont E, Albert AY, Wang C, Dos Santos SJ, Coutl\u00e9e F, Lee M, et al. Vaginal microbiota associated with oncogenic HPV in a cohort of HPV-vaccinated women living with HIV. Int J STD AIDS. 2022;33:847\u2013855. https:\/\/doi.org\/10.1177\/09564624221094926.","DOI":"10.1177\/09564624221094926"},{"key":"777_CR10","doi-asserted-by":"publisher","unstructured":"Chen Y, Qiu X, Wang W, Li D, Wu A, Hong Z, et al. Human papillomavirus infection and cervical intraepithelial neoplasia progression are associated with increased vaginal microbiome diversity in a Chinese cohort. BMC Infect Dis. 2020;20:629. https:\/\/doi.org\/10.1186\/s12879-020-05337-2.","DOI":"10.1186\/s12879-020-05337-2"},{"key":"777_CR11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.trsl.2016.07.004","volume":"179","author":"M Kyrgiou","year":"2017","unstructured":"Kyrgiou M, Mitra A, Moscicki A-B. Does the vaginal microbiota play a role in the development of cervical cancer? Transl Res. 2017;179:168\u201382. https:\/\/doi.org\/10.1016\/j.trsl.2016.07.004.","journal-title":"Transl Res"},{"key":"777_CR12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40168-016-0203-0","volume":"4","author":"A Mitra","year":"2016","unstructured":"Mitra A, MacIntyre DA, Marchesi JR, Lee YS, Bennett PR, Kyrgiou M. The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next? Microbiome. 2016;4:58. https:\/\/doi.org\/10.1186\/s40168-016-0203-0.","journal-title":"Microbiome"},{"key":"777_CR13","doi-asserted-by":"publisher","first-page":"19095","DOI":"10.1038\/s41598-020-76003-7","volume":"10","author":"EO Dareng","year":"2020","unstructured":"Dareng EO, Ma B, Adebamowo SN, Famooto A, Ravel J, Pharoah PP, Adebamowo CA. Vaginal microbiota diversity and paucity of Lactobacillus species are associated with persistent hrHPV infection in HIV negative but not in HIV positive women. Sci Rep. 2020;10:19095. https:\/\/doi.org\/10.1038\/s41598-020-76003-7.","journal-title":"Sci Rep"},{"key":"777_CR14","doi-asserted-by":"publisher","first-page":"922554","DOI":"10.3389\/fcimb.2022.922554","volume":"12","author":"B Fang","year":"2022","unstructured":"Fang B, Li Q, Wan Z, OuYang Z, Zhang Q. Exploring the Association Between Cervical Microbiota and HR-HPV Infection Based on 16S rRNA Gene and Metagenomic Sequencing. Front Cell Infect Microbiol. 2022;12:922554. https:\/\/doi.org\/10.3389\/fcimb.2022.922554.","journal-title":"Front Cell Infect Microbiol"},{"key":"777_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/1471-0528.15854","volume":"127","author":"J Norenhag","year":"2020","unstructured":"Norenhag J, Du J, Olovsson M, Verstraelen H, Engstrand L, Brusselaers N. The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis. BJOG Int J Obstet Gynaecol. 2020;127:171\u201380. https:\/\/doi.org\/10.1111\/1471-0528.15854.","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"777_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s40246-025-00795-w","volume":"19","author":"HH Rashwan","year":"2025","unstructured":"Rashwan HH, Ali MH, Mostafa MM, Ramadan R, Mysara M. Insights into the tripartite relationship between cervical cancer, human papillomavirus, and the vaginal microbiome: a mega-analysis. Hum Genomics. 2025;19:89. https:\/\/doi.org\/10.1186\/s40246-025-00795-w.","journal-title":"Hum Genomics"},{"key":"777_CR17","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.3390\/v14122674","volume":"14","author":"M Camargo","year":"2022","unstructured":"Camargo M, Vega L, Mu\u00f1oz M, S\u00e1nchez R, Patarroyo ME, Ram\u00edrez JD, Patarroyo MA. Changes in the Cervical Microbiota of Women with Different High-Risk Human Papillomavirus Loads. Viruses. 2022;14:2674. https:\/\/doi.org\/10.3390\/v14122674.","journal-title":"Viruses"},{"key":"777_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12985-020-01420-z","volume":"17","author":"M Berggrund","year":"2020","unstructured":"Berggrund M, Gustavsson I, Aarnio R, Lindberg JH, Sanner K, Wikstr\u00f6m I, Enroth S, Bunikis I, Olovsson M, Gyllensten U. Temporal changes in the vaginal microbiota in self-samples and its association with persistent HPV16 infection and CIN2+. Virol J. 2020;17:147. https:\/\/doi.org\/10.1186\/s12985-020-01420-z.","journal-title":"Virol J"},{"key":"777_CR19","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/GME.0000000000000130","volume":"21","author":"RM Brotman","year":"2014","unstructured":"Brotman RM, Shardell MD, Gajer P, Fadrosh D, Chang K, Silver MI, Viscidi RP, Burke AE, Ravel J, Gravitt PE. Association between the vaginal microbiota, menopause status, and signs of vulvovaginitis. Menopause. 2014;21:450\u20138. https:\/\/doi.org\/10.1097\/GME.0000000000000130.","journal-title":"Menopause"},{"key":"777_CR20","doi-asserted-by":"publisher","unstructured":"Mitra A, MacIntyre DA, Ntritsos G, Smith A, Tsilidis KK, Marchesi JR, Bennett PR, Moscicki AB, Kyrgiou M. The vaginal microbiota associates with the regression of untreated cervical intraepithelial neoplasia 2 lesions. Nat Commun. 2020;11:1999. https:\/\/doi.org\/10.1038\/s41467-020-15856-y.","DOI":"10.1038\/s41467-020-15856-y"},{"key":"777_CR21","doi-asserted-by":"publisher","first-page":"e1008376","DOI":"10.1371\/journal.ppat.1008376","volume":"16","author":"M Usyk","year":"2020","unstructured":"Usyk M, Zolnik CP, Castle PE, Porras C, Herrero R, Gradissimo A, Gonzalez P, Safaeian M, Schiffman M, Burk RD, Costa Rica HPV Vaccine Trial (CVT) Group. Cervicovaginal microbiome and natural history of HPV in a longitudinal study. PLOS Pathog. 2020;16:e1008376. https:\/\/doi.org\/10.1371\/journal.ppat.1008376.","journal-title":"PLOS Pathog"},{"key":"777_CR22","doi-asserted-by":"publisher","first-page":"e01619","DOI":"10.1128\/mbio.01619-22","volume":"13","author":"MA Molina","year":"2022","unstructured":"Molina MA, Coenen BA, Leenders WPJ, Andralojc KM, Huynen MA, Melchers WJG. Assessing the Cervicovaginal Microbiota in the Context of hrHPV Infections: Temporal Dynamics and Therapeutic Strategies. mBio. 2022;13:e01619\u201322. https:\/\/doi.org\/10.1128\/mbio.01619-22.","journal-title":"mBio"},{"key":"777_CR23","doi-asserted-by":"publisher","first-page":"e29451","DOI":"10.1002\/jmv.29451","volume":"96","author":"N Zhang","year":"2024","unstructured":"Zhang N, Chen Z, Huang M, Lu Q, Yang H, Xiang J, Yang J, Peng Y, Wang G, Han N, Min X, Huang J. Cervicovaginal microbiota long-term dynamics and prediction of different outcomes in persistent human papillomavirus infection. J Med Virol. 2024;96:e29451. https:\/\/doi.org\/10.1002\/jmv.29451.","journal-title":"J Med Virol"},{"key":"777_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/QAD.0000000000002381","volume":"34","author":"JHHM an De Wijgert","year":"2020","unstructured":"Van De Wijgert JHHM, Gill AC, Chikandiwa A, Verwijs MC, Kelly HA, Omar T, Delany-Moretlwe S, Segondy M, Francis S, Darby AC, Mayaud P. Human papillomavirus infection and cervical dysplasia in HIV-positive women: potential role of the vaginal microbiota. AIDS. 2020;34:115\u201325. https:\/\/doi.org\/10.1097\/QAD.0000000000002381.","journal-title":"AIDS"},{"key":"777_CR25","doi-asserted-by":"publisher","first-page":"569022","DOI":"10.3389\/fcimb.2020.569022","volume":"10","author":"A-B Moscicki","year":"2020","unstructured":"Moscicki A-B, Shi B, Huang H, Barnard E, Li H. Cervical-Vaginal Microbiome and Associated Cytokine Profiles in a Prospective Study of HPV 16 Acquisition, Persistence, and Clearance. Front Cell Infect Microbiol. 2020;10:569022. https:\/\/doi.org\/10.3389\/fcimb.2020.569022.","journal-title":"Front Cell Infect Microbiol"},{"key":"777_CR26","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.1002\/cam4.4801","volume":"11","author":"C Li","year":"2022","unstructured":"Li C, Zhang Z, Yang Y, Liao H. Changes in the cervicovaginal microbiota composition of HPV16 -infected patients after clinical treatment. Cancer Med. 2022;11:5037\u201349. https:\/\/doi.org\/10.1002\/cam4.4801.","journal-title":"Cancer Med"},{"key":"777_CR27","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13073-021-00977-w","volume":"13","author":"A Mitra","year":"2021","unstructured":"Mitra A, MacIntyre DA, Paraskevaidi M, Moscicki A-B, Mahajan V, Smith A, Lee YS, Lyons D, Paraskevaidis E, Marchesi JR, Bennett PR, Kyrgiou M. The vaginal microbiota and innate immunity after local excisional treatment for cervical intraepithelial neoplasia. Genome Med. 2021;13:176. https:\/\/doi.org\/10.1186\/s13073-021-00977-w.","journal-title":"Genome Med"},{"key":"777_CR28","doi-asserted-by":"publisher","first-page":"540900","DOI":"10.3389\/fcimb.2020.540900","volume":"10","author":"E Caselli","year":"2020","unstructured":"Caselli E, D\u2019Accolti M, Santi E, Soffritti I, Conzadori S, Mazzacane S, Greco P, Contini C, Bonaccorsi G. Vaginal Microbiota and Cytokine Microenvironment in HPV Clearance\/Persistence in Women Surgically Treated for Cervical Intraepithelial Neoplasia: An Observational Prospective Study. Front Cell Infect Microbiol. 2020;10:540900. https:\/\/doi.org\/10.3389\/fcimb.2020.540900.","journal-title":"Front Cell Infect Microbiol"},{"key":"777_CR29","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1186\/s12967-024-05332-2","volume":"22","author":"Y Wang","year":"2024","unstructured":"Wang Y, Wang T, Yan D, Zhao H, Wang M, Liu T, Fan X, Xu X. Vaginal microbial profile of cervical cancer patients receiving chemoradiotherapy: the potential involvement of Lactobacillus iners in recurrence. J Transl Med. 2024;22:575. https:\/\/doi.org\/10.1186\/s12967-024-05332-2.","journal-title":"J Transl Med"},{"key":"777_CR30","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1111\/1471-0528.16816","volume":"128","author":"L Goodfellow","year":"2021","unstructured":"Goodfellow L, Verwijs M, Care A, Sharp A, Ivandic J, Poljak B, Roberts D, Bronowski C, Gill A, Darby A, Alfirevic A, Muller-Myhsok B, Alfirevic Z, Van De Wijgert J. Vaginal bacterial load in the second trimester is associated with early preterm birth recurrence: a nested case\u2013control study. BJOG Int J Obstet Gynaecol. 2021;128:2061\u201372. https:\/\/doi.org\/10.1111\/1471-0528.16816.","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"777_CR31","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.tim.2016.11.007","volume":"25","author":"MI Petrova","year":"2017","unstructured":"Petrova MI, Reid G, Vaneechoutte M, Lebeer S. Lactobacillus iners : Friend or Foe? Trends Microbiol. 2017;25:182\u201391. https:\/\/doi.org\/10.1016\/j.tim.2016.11.007.","journal-title":"Trends Microbiol"},{"key":"777_CR32","doi-asserted-by":"publisher","unstructured":"Gajer P, Brotman RM, Bai G, Sakamoto J, Sch\u00fctte UME, Zhong X, Koenig SSK, Fu L, Ma Z, Zhou X, Abdo Z, Forney LJ, Ravel J. Temporal dynamics of the human vaginal microbiota. Sci Transl Med. 2012;4. https:\/\/doi.org\/10.1126\/scitranslmed.3003605.","DOI":"10.1126\/scitranslmed.3003605"},{"key":"777_CR33","doi-asserted-by":"publisher","first-page":"792787","DOI":"10.3389\/fcimb.2021.792787","volume":"11","author":"N Zheng","year":"2021","unstructured":"Zheng N, Guo R, Wang J, Zhou W, Ling Z. Contribution of Lactobacillus iners to Vaginal Health and Diseases: A Systematic Review. Front Cell Infect Microbiol. 2021;11:792787. https:\/\/doi.org\/10.3389\/fcimb.2021.792787.","journal-title":"Front Cell Infect Microbiol"},{"key":"777_CR34","doi-asserted-by":"publisher","first-page":"4688","DOI":"10.1073\/pnas.1000086107","volume":"108","author":"JM Macklaim","year":"2011","unstructured":"Macklaim JM, Gloor GB, Anukam KC, Cribby S, Reid G. At the crossroads of vaginal health and disease, the genome sequence of Lactobacillus iners AB-1. Proc Natl Acad Sci. 2011;108:4688\u201395. https:\/\/doi.org\/10.1073\/pnas.1000086107.","journal-title":"Proc Natl Acad Sci"},{"key":"777_CR35","doi-asserted-by":"publisher","DOI":"10.22074\/cellj.2016.3833","author":"E Motevaseli","year":"2016","unstructured":"Motevaseli E, Azam R, Akrami SM, Mazlomy M, Saffari M, Modarressi MH, et al. The effect of Lactobacillus crispatus and Lactobacillus rhamnosus culture supernatants on expression of autophagy genes and HPV E6 and E7 oncogenes in the HeLa cell line. Cell J. 2016;17(4):601\u20137.","journal-title":"Cell Journal"},{"key":"777_CR36","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3389\/fmicb.2020.00551","volume":"11","author":"H Kaur","year":"2020","unstructured":"Kaur H, Merchant M, Haque MM, Mande SS. Crosstalk Between Female Gonadal Hormones and Vaginal Microbiota Across Various Phases of Women\u2019s Gynecological Lifecycle. Front Microbiol. 2020;11:551. https:\/\/doi.org\/10.3389\/fmicb.2020.00551.","journal-title":"Front Microbiol"},{"key":"777_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12941-020-0347-4","volume":"19","author":"N Kalia","year":"2020","unstructured":"Kalia N, Singh J, Kaur M. Microbiota in vaginal health and pathogenesis of recurrent vulvovaginal infections: a critical review. Ann Clin Microbiol Antimicrob. 2020;19:5. https:\/\/doi.org\/10.1186\/s12941-020-0347-4.","journal-title":"Ann Clin Microbiol Antimicrob"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-026-00777-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-026-00777-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-026-00777-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:17:49Z","timestamp":1790817469000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13027-026-00777-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["777"],"URL":"https:\/\/doi.org\/10.1186\/s13027-026-00777-0","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"64"}}